The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
AGEX THEREPEUTICS INCCOM00848H108300185,185SH SOLE 185,18500
ALLIANCE DATA SYSTEMS CORPCOM01858110829,745265,370SH SOLE 265,37000
CIMPRESS PLCSHS EUROG2143T103391,1573,906,492SH SOLE 3,906,49200
CREDIT ACCEP CORP MICHCOM225310101626,3531,738,758SH SOLE 1,738,75800
LINEAGE CELL THERAPEUTICS INCOM53566P1094,3521,851,851SH SOLE 1,851,85100
SYSTEMAX INCCOM87185110173,0961,777,633SH SOLE 1,777,63300
VAPOTHERM INCCOM92210710761,4252,557,243SH SOLE 2,557,24300
WAYFAIR INCCL A94419L1011,250,5743,973,230SH SOLE 3,973,23000
WORLD ACCEP CORP DELCOM981419104264,3852,037,495SH SOLE 2,037,49500
YELP INCCL A985817105200,8905,151,016SH SOLE 5,151,01600